Ana Costa

Dr. Ana Costa

Faculty of Pharmacy, Lisbon, Lisboa, Portugal
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
CFCatarina Faria-Silva
Catarina Faria-Silva
AAAndreia Ascenso
Andreia Ascenso
ACAna Costa
Ana Costa
Joana MartoJoana Marto
Joana Marto
MCManuela Carvalheiro
Manuela Carvalheiro
Sandra SimõesSandra Simões
Sandra Simões

1 March 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
ACAna Costa
Ana Costa
Bruno SarmentoBruno Sarmento
Bruno Sarmento
VSVítor Seabra
Vítor Seabra

27 October 2012 in Biomatter
Verified
Journal Article
Open access
Pedro FontePedro Fonte
Pedro Fonte
SSSandra Soares
Sandra Soares
ACAna Costa
Ana Costa
José Carlos AndradeJosé Carlos Andrade
José Carlos Andrade
VSVítor Seabra
Vítor Seabra
Bruno SarmentoBruno Sarmento
Bruno Sarmento
PLGA nanoparticles are useful to protect and deliver proteins in a localized or targeted manner, with a long-term systemic delivery pattern intended to last for a period of time, depending on polym...

1 July 2016 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
ACAna Costa
Ana Costa
Marina PinheiroMarina Pinheiro
Marina Pinheiro
JMJoana Magalhães
Joana Magalhães
RRRicardo Ribeiro
Ricardo Ribeiro
VSVitor Seabra
Vitor Seabra
Bruno SarmentoBruno Sarmento
Bruno Sarmento

24 September 2014 in Biomacromolecules
Verified
Journal Article
Closed access
Pedro FontePedro Fonte
Pedro Fonte
SSSandra Soares
Sandra Soares
Flávia SousaFlávia Sousa
Flávia Sousa
ACAna Costa
Ana Costa
VSVítor Seabra
Vítor Seabra
Bruno SarmentoBruno Sarmento
Bruno Sarmento

4 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
TLTânia Laranjeira
Tânia Laranjeira
ACAna Costa
Ana Costa
CFCatarina Faria-Silva
Catarina Faria-Silva
Daniela RibeiroDaniela Ribeiro
Daniela Ribeiro
JOJosé Miguel P. Ferreira de Oliveira
José Miguel P. Ferreira de Oliveira
AAAndreia Ascenso
Andreia Ascenso
Tomato producing and processing industries present undoubted potential for industrial discarded products valorization whether due to the overproduction of fresh tomatoes or to the loss during processing. Although tomato by-products are not yet considered a raw material, several studies have suggested innovative and profitable applications. It is often referred to as “tomato pomace” and is quite rich in a variety of bioactive compounds. Lycopene, vitamin C, β-carotene, phenolic compounds, and tocopherol are some of the bioactives herein discussed. Tomato by-products are also rich in minerals. Many of these compounds are powerful antioxidants with anti-inflammatory properties besides modulating the immune system. Several researchers have focused on the possible application of natural ingredients, especially those extracted from foods, and their physiological and pharmacological effects. Herein, the effects of processing and further applications of the bioactive compounds present in tomato by-products were carefully reviewed, especially regarding the anti-inflammatory and anti-cancer effects. The aim of this review was thus to highlight the existing opportunities to create profitable and innovative applications for tomato by-products in health context.